We serve Chemical Name:2-(4-Formylphenoxy)propanoic acid CAS:51264-78-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(4-Formylphenoxy)propanoic acid
CAS.NO:51264-78-9
Synonyms:2-(4-formylphenoxy)propanoic acid
Molecular Formula:C10H10O4
Molecular Weight:194.18400
HS Code:2918990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:371ºC at 760mmHg
Density:1.268g/cm3
Index of Refraction:1.573
PSA:63.60000
Exact Mass:194.05800
LogP:1.35100
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1 / PGIII
Packing Group:
Contact us for information like 2-(4-formylphenoxy)propanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-formylphenoxy)propanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-formylphenoxy)propanoic acid Use and application,2-(4-formylphenoxy)propanoic acid technical grade,usp/ep/jp grade.
Related News: Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. (R)-5-(2-(1-oxidaneyl)-13,24,33,44,53,63-hexaoxin-4-yl)-23,43,54-hexaoxane-2,4,5-triol manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 3-(2,4-Dihydroxy-3,3-dimethyl-butyrylamino)-propionic acid 2-((9R,10S,11S,13S,16R,17S)-9-fluoro-11,16,17-trihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester suppliers In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks. 1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-3-(1,2,4-oxadiazol-3-yl)-1H-pyrazol-5-amine vendor & factory.
